| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/13/2008 | CN100368014C Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 02/12/2008 | US7329644 Preparation and use of cyclic and branched peptides and their labelled derivatives as therapeutic agents, cholecystokinin agonists or antagonists, and diagnostic agents to identify and locate tumours |
| 02/12/2008 | US7329511 Nucleic acid encoding GAD65 |
| 02/12/2008 | US7329414 Biodegradable polymer for marking tissue and sealing tracts |
| 02/12/2008 | US7329401 Cyclooxygenase-2 selective agents useful as imaging probes and related methods |
| 02/12/2008 | US7329400 Generator for rhenium-188 |
| 02/12/2008 | CA2411577C Stabiliser for radiopharmaceuticals |
| 02/12/2008 | CA2274132C Macrocyclic metal complex carboxylic acids, use and method for the production thereof |
| 02/07/2008 | WO2008016431A2 Bi-specific monoclonal antibody (specific for both cd3 and cd11b) therapeutic drug |
| 02/07/2008 | WO2006136564A9 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 02/07/2008 | WO2005117999A3 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface |
| 02/07/2008 | US20080031815 Pet imaging of vascular endothelial growth factor receptor (VEGFR), compositions for VEGF cancer imaging, and methods of VEGF cancer imaging |
| 02/07/2008 | US20080031813 Targeted Combination Immunotherapy of Cancer and Infectious Diseases |
| 02/07/2008 | US20080031812 Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates, thereof, compositions and methods of synthesis and use |
| 02/07/2008 | US20080031811 Method For Preparing Radioactive Film |
| 02/06/2008 | CN100366297C Preparation of M(CO)3-complexes by solid phase techniques via metal assisted cleavage from the solid support |
| 02/05/2008 | US7326685 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 02/05/2008 | US7326529 Using cancer specific genes |
| 02/05/2008 | US7326403 That can selectively accumulate in tumor cells or tumor tissue for use as a scintillation imaging agent; 1-alkyl-2-((3-alkyl-5-(3-(iodophenylalkyl)benzothiazolin-2-yliden)-4-oxothiazolidin-2-ylidene)methyl)pyridinium p-toluenesulfonate |
| 02/05/2008 | US7326402 Method of diagnosing, monitoring, staging, imaging and treating cancer |
| 01/31/2008 | WO2008011711A1 Cancerous disease modifying antibodies |
| 01/31/2008 | WO2008011710A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 01/31/2008 | WO2007122488A3 Radiofluorinated compounds and their preparation |
| 01/31/2008 | WO2007066115B1 Novel imaging agents for fibrosis |
| 01/31/2008 | WO2007052267A3 Biodegradable composite for internal local radiotherapy |
| 01/31/2008 | WO2007033096A3 Methods and compositions for diagnosis and treatment of disorders involving macrophages |
| 01/31/2008 | US20080027003 Peptides Useful for Treating Gnrh Associated Diseases |
| 01/31/2008 | US20080025915 Technetium-And Rhenium-Bis (Heteroaryl) Complexes, And Methods Of Use Thereof |
| 01/31/2008 | US20080025914 Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug |
| 01/31/2008 | US20080025913 Novel Anti-Dc-Sign Antibodies |
| 01/31/2008 | CA2666515A1 Cancerous disease modifying antibodies |
| 01/31/2008 | CA2666464A1 Cytotoxicity mediation of cells evidencing surface expression of cd63 |
| 01/30/2008 | EP0820473B2 Biodegradable polyacetal polymers and formation and use |
| 01/30/2008 | CN100365021C Nucleic protein 'Shoca'-a component of wnt signal transmission channel |
| 01/29/2008 | US7323566 Apomorphine derivatives; radioimaging agents upon incorporation of radionuclides; neuronal function diagnosis |
| 01/29/2008 | US7323168 Immunotherapy for chronic myelocytic leukemia |
| 01/29/2008 | CA2226058C 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
| 01/24/2008 | WO2008011496A2 Method for radiolabeling formulations for gamma scintigraphy assesment |
| 01/24/2008 | WO2008009444A1 Use of ethanol for stabilizing a single-vial liquid formulation of a radiolabeled peptide |
| 01/24/2008 | WO2007137760A3 Dimeric molecular complexes |
| 01/24/2008 | US20080021077 Bioavailability, nontoxic; 2-(3'-Iodo-4'-aminophenyl)-6-methoxybenzothiazole |
| 01/24/2008 | US20080021005 Pegylated Ion Channel Modulating Compounds |
| 01/24/2008 | US20080019971 36P6D5: secreted tumor antigen |
| 01/24/2008 | US20080019906 Rreacting a hydrated 18F-radiolabeled fluoride ion source with an unsaturated carrier compound in a nucleophilic reaction to produce an 18F-radiolabeled carrier compound and reacting the 18F-radiolabeled carrier compound with a nucleophilic composition in a second nucleophilic reaction; tomography |
| 01/24/2008 | US20080019905 Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection |
| 01/24/2008 | US20080019904 System For Manufacturing Micro-Sheres |
| 01/24/2008 | CA2657915A1 Improvement of arginase levels/activity |
| 01/23/2008 | EP1879921A2 Host cell specific binding molecules capable of neutralizing viruses and uses thereof |
| 01/23/2008 | EP1879627A2 Methods for measuring cholesterol metabolism and transport |
| 01/23/2008 | EP1879626A2 Amphiphilic polymers and methods of use thereof |
| 01/23/2008 | EP1682113B1 Inhibitor imaging agents |
| 01/23/2008 | EP1009446B1 Imaging methods and compositions |
| 01/23/2008 | CN101111270A Bridgehead radiolabelled compounds and methods of using the same |
| 01/23/2008 | CN100363371C Application of 99TcmN (CPEDTC)2 compounding agent in tumour imaging field |
| 01/22/2008 | US7321049 Synthesis of [13C] and [2H] substituted methacrylic acid, [13C] and [2H] substituted methyl methacrylate and/or related compounds |
| 01/22/2008 | US7321045 Vitronectin receptor antagonist pharmaceuticals |
| 01/22/2008 | US7321027 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 01/22/2008 | US7320784 Metal support surface, conjugate releasably bound to the support surface, the conjugate comprising a ligand and a targeting molecule;wherein the conjugate coordinates with a complex-forming metal ion so that labeled conjugate is released; radiotherapy and as imaging agents in medical diagnostics |
| 01/22/2008 | US7320783 A method for treating a wound, comprising: providing an MMP prodomain peptide, and a subject having at least one wound; and administering said peptide to said subject under conditions such that the healing of said wound is promoted and |
| 01/22/2008 | CA2185114C Recombinant humanized anti-lewis y antibodies |
| 01/17/2008 | WO2008007146A1 Process for preparing particles of proteinaceous material |
| 01/17/2008 | WO2008006658A1 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 01/17/2008 | WO2007136707A3 Methods and compositions related to eosinophil regulation |
| 01/17/2008 | WO2007076371A3 Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same |
| 01/17/2008 | US20080014175 Methods and Compositions for Viral Enhancement of Cell Killing |
| 01/17/2008 | US20080014148 Perturbed membrane-binding compounds and methods of using the same |
| 01/17/2008 | CA2657277A1 Process for preparing particles of proteinaceous material |
| 01/16/2008 | EP1878749A2 Individulized anti-cancer antibodies |
| 01/16/2008 | EP1878746A2 Human monoclonal antibodies to epidermal growth factor receptor |
| 01/16/2008 | EP1877175A2 Apparatus and method for making radiopharmaceuticals |
| 01/16/2008 | EP1877105A1 A method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate |
| 01/16/2008 | EP1877100A2 Liposomes |
| 01/16/2008 | EP1173480B1 Stereoselective antifibrillogenic peptides |
| 01/16/2008 | EP1077998B1 Labelled glutamine and lysine analogues |
| 01/16/2008 | CN101107267A Cytotoxicity mediation of cells evidencing surface expression of MCSP |
| 01/16/2008 | CN101107017A Stabilised 99mtc compositions |
| 01/16/2008 | CN101104627A 18F-FDG automatization synthetic method and device |
| 01/16/2008 | CN100361711C Diagnostic imaging contrast agents with extended blood retention |
| 01/15/2008 | US7319149 Chelants and macrocyclic metal complex radiopharmaceuticals thereof |
| 01/15/2008 | US7319139 TAG-72 specific CH2 domain deleted antibodies |
| 01/10/2008 | WO2008005991A1 Invisible light fluorescent platelets for intraoperative detection of vascular thrombosis |
| 01/10/2008 | WO2008005889A2 Tetanus toxin fragment c based imaging agents and methods, and confocal microscopy dataset processes |
| 01/10/2008 | WO2008005824A1 Adjuvants and methods of use |
| 01/10/2008 | WO2008003954A1 Dye imaging agents |
| 01/10/2008 | WO2007062855A3 Radioimmunoconjugate for human cd66 for the treatment of multiple myeloma |
| 01/10/2008 | US20080009842 Method and apparatus for emr treatment |
| 01/10/2008 | US20080008649 Gastrin Releasing Peptide Compounds |
| 01/10/2008 | US20080008648 Treatment of Cancer With a Novel Anti-Il13 Monoclonal Antibody |
| 01/10/2008 | US20080008647 Biodegradable polymer particles |
| 01/10/2008 | CA2656104A1 Tetanus toxin fragment c based imaging agents and methods, and confocal microscopy dataset processes |
| 01/10/2008 | CA2655947A1 Compositions comprising nkt cell agonist compounds and methods of use |
| 01/09/2008 | EP1875240A2 The preparation of molecular imaging probes using click chemistry |
| 01/09/2008 | EP1874789A1 Fluorinated 3'-deoxythymidine derivatives, a method for their preparation and their use |
| 01/09/2008 | EP1874712A2 Preparations of 11c methyl iodide and of the radioligand 11c gb67 |
| 01/09/2008 | EP1434604A4 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| 01/09/2008 | EP1307237B9 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof |
| 01/09/2008 | EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/09/2008 | CN101099725A Method for preparing composite substrate multifunctional arterial embolic agent |
| 01/09/2008 | CN100360628C Adhesive |
| 01/09/2008 | CN100360567C RS7 antibodies |